According to Drugs Register Regulation issued in 2007 , re-evaluation on the quality of launched oral solid drugs is requested, with the purpose to perform the assessement on quality and efficacy of drugs. The key re-evaluation measures are the comparision of dissolution rate, related impurities , and bio-equivalance. Re-development is requested under the condition of inconsistence is exsisted.
 
Baolong can provide the follwoing consistency evaluation services on generic drugs for solid oral and parenteral  formulations:
- Prepare documentations to import &filling reference drugs
 - Screen and select qualified supplier of API
 - Perform supplementary studies to upgrade API quality
 - Perform formulation optimization and studies for process control.
 -  Perform studies on dissolution profile similarity with RLD in different medium
 - Perform studies on impurities profile, including impurity identification and elemental impurity study.
 - Perform studies on stability, package compatibility and safety evaluation, etc.
 - Perform scale up study and process validation in GMP plant.
 - Prepare and submit registration dossiers to CDE
 
Business advantages

Workflow
